Medtronic PLC (BSP:MDTC34)
R$ 254.5 1.06 (0.42%) Market Cap: 640.63 Bil Enterprise Value: 754.64 Bil PE Ratio: 29.64 PB Ratio: 2.35 GF Score: 77/100

Medtronic PLC at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript

Feb 25, 2021 / 07:25PM GMT
Release Date Price: R$327.3 (+0.93%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Hello, everybody, thank you so much for coming to the next session. This one is with Medtronic, represented by Brett Wall. He is the Executive Vice President and President of the Neuroscience portfolio, which includes 5 operating units: Neuromodulation, Cranial & Spinal Technologies, Neurovascular, Pelvic Health, and EMT. Brett, thank you so much for joining us.

Uh-oh, I don't hear you. There you go.

Brett A. Wall
Medtronic plc - Executive VP & President of Neuroscience Portfolio

What I was saying, it's a pleasure to be here. So hopefully, you can hear me now.

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Great, cool. Hello, great to hear you. Love technology, so Brett, can you tell us a little bit about yourself, your time at Medtronic and how long you've been heading up this business unit?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot